Zscaler heads into its September 1 earnings print with analysts actively raising targets and the stock up 24% over the past month — yet options traders are quietly building the most defensive posture seen in weeks.
The analyst moves are the headline story this week. Multiple firms raised price targets on Tuesday alone. Mizuho lifted its target from $185 to $210, while Wells Fargo moved from $180 to $210 — both maintaining positive ratings. TD Cowen and Stifel also raised targets earlier in the week, to $200 each. Cantor Fitzgerald reiterated its Overweight with a $225 target, the highest on the Street. The direction of travel is unanimous: 27 buy-equivalent ratings, a consensus mean target of $195.71, and no visible downgrades in recent activity. At $185.70, the stock is trading just below the mean target, which compresses the implied upside to around 5% — a narrow margin that puts the September print firmly in the driver's seat.
Options positioning tells a more cautious story beneath that bullish surface. The put/call ratio has climbed to 0.80, nearly two standard deviations above its 20-day average of 0.76, and the highest defensive reading in recent weeks. That jump in put demand is notable precisely because it arrived alongside the analyst target hikes — hedgers are buying protection into the move, not fading it. The 52-week PCR range runs from 0.60 to 1.07, so current positioning is elevated but not extreme. Short interest, by contrast, is not the story here: bears have been retreating fast, with SI falling nearly 13% over the past week to 4.4% of the float, down from over 6% in early July. Borrow costs confirm the lack of conviction on the short side, running at just 0.33%. Availability is enormous — roughly 85 million shares remain available to borrow against 7 million shorted — so there is no squeeze dynamic in play.
The bull-bear debate on ZS hinges on execution rather than market opportunity. Bulls point to cloud-native zero-trust architecture, accelerating AI-driven upsell potential, and the expansion into the 2,000–10,000 employee market as a multi-year growth lever. Bears flag the more immediate concerns: a post-earnings reset that took the stock down 31% in a single session on May 26 is a recent and vivid reminder of how badly this name can trade on a guidance miss. That fall erased weeks of gains in one day. EPS momentum scores remain strong — ranking in the 84th–92nd percentile on both 30 and 90-day forward estimates — but the EPS surprise factor score sits at just 17, meaning the company has historically underwhelmed relative to expectations even as estimates climb. The valuation is not demanding by hypergrowth standards — PE near 36x, EV/EBITDA around 23x — and the EV/EBITDA multiple has actually compressed by five turns over the past month as the stock lagged and estimates moved up.
On the institutional side, the two largest holders — Ajay Mangal and founder Jagtar Chaudhry — together control over 34% of shares, providing a stable anchor to the cap table. BlackRock added 1.3 million shares through July, and Victory Capital added 720,000. The insider picture is less constructive: CFO Kevin Rubin executed a series of small sales at prices in the mid-$140s in late July, well below the current level, though the trade significance scores were low and the sizes immaterial.
Cybersecurity peers had a mixed week. CRWD fell 4% and PANW dropped 2.5%, while ZS gained 4% — an outperformance that looks driven partly by the analyst target cluster. ESTC was the week's standout, up 11%, though with lower correlation to ZS. The key variable to track now is the September 1 earnings release: given the May disaster, the Street will be watching guidance language around large deal closures and new logo adds at least as closely as the reported revenue line.
See the live data behind this article on ORTEX.
Open ZS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
